Related Experiment Video
Updated: Jul 23, 2025

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Neutropenia and antibiotics: when, what, how and why?
Jana Dickter1, Cathy Logan2, Randy Taplitz1
1Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte.
Antibiotic use in neutropenia requires careful consideration. While early treatment for febrile neutropenia is crucial, de-escalation or stopping antibiotics early may be safe for many patients, balancing risks and benefits.
Area of Science:
- Infectious Diseases
- Hematology
- Oncology
Background:
- Neutropenia, a condition characterized by a low white blood cell count, increases susceptibility to infection.
- Antibiotic management in neutropenic patients is complex, balancing the risk of infection with the potential harms of antibiotic exposure.
Approach:
- This review synthesizes recent literature on antibiotic utilization in neutropenic patient populations.
- Focuses on evaluating the evidence for prophylactic and therapeutic antibiotic strategies.
Key Points:
- Prophylactic antibiotic use in neutropenia is linked to potential risks and offers limited mortality benefits.
- Early antibiotic administration for febrile neutropenia (FN) is critical.
- Early de-escalation or discontinuation of antibiotics in FN may be a safe strategy for select patients.
Conclusions:
- Evolving understanding of antibiotic risks and benefits, coupled with enhanced risk assessment tools, is reshaping clinical paradigms.
- Optimizing antibiotic use in neutropenia involves individualized patient management and careful monitoring.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Urinary Tract Infection IV: Nursing Management
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

